Clinical trials
Patient Outcomes clinical trials
Below are recruiting patient outcomes clinical trials, each written for real people, not researchers. We’re tracking 648 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06185569Recruiting
French study on outcomes in HR+/HER2- early breast cancer patients with Oncotype DX
This study looks at how well treatments work for people with early-stage, hormone receptor-positive, HER2-negative breast cancer when the Oncotype DX test helps guide therapy. It aims to understand real-world outcomes in French patients.
BesançonAges 18 years+ - NCT05028777Recruiting
People with a heart clot who can join a hospital record study
This study looks at people age 18+ who were found to have a blood clot in the left side of the heart (left ventricular thrombus) on scans between 2013 and 2020. It will compare how different blood-thinner medicines were used and what outcomes occurred.
BernAges 18 years+ - NCT07692256RecruitingPhase 2
Empagliflozin for heart failure in children
This trial tests if empagliflozin, a diabetes medicine that also helps the heart, can improve symptoms in children with heart failure. It may help kids with severe symptoms or high levels of a heart stress marker called BNP.
Cairo, Cairo GovernorateAges 1 month–18 years - NCT07593248Recruiting
Real-World Lung Cancer Outcomes With Targeted Drug Therapy in China
This study looks at how well patients with early-stage lung cancer (that has been surgically removed) do when treated with a targeted drug called EGFR-TKI to prevent cancer from coming back. Researchers will track actual patient outcomes in China from 2023 to 2026.
BeijingAges 18 years+ - NCT06728007Recruiting
Horseshoe kidney study in children
This study follows children with a horseshoe kidney to understand how the condition affects kidney health and to identify any related birth defects. It may help researchers learn more about this condition and improve care.
Bologna, BolognaAges Up to 18 years - NCT06694259Recruiting
Laser vs. freezing for retinal detachment repair
This trial compares two methods (laser or freezing) to seal tears in the retina after a procedure to reattach it. It may help people with a specific type of retinal detachment where the tear is in the upper part of the eye.
SplitAges 18 years+ - NCT07372131Recruiting
Shorter antibiotics for high-risk fever with low white blood cells
This study looks at how long antibiotics should be given to cancer patients with fever and very low white blood cell counts after finding a certain type of bacteria (Gram-negative) in their blood. The goal is to find the best treatment duration to help patients recover without complications.
Rozzano, MilanAges 18 years+ - NCT07270757Recruiting
Pre-ablation exercise program for atrial fibrillation
This study tests whether a short exercise and education program before a first-time ablation for atrial fibrillation improves your recovery and heart fitness. It's for people with mild or no heart failure symptoms and a well-pumping heart.
Nanjing, Please SelectAges 18–70 - NCT07187479Recruiting
Testing a new insulin approach for kidney disease and diabetes
This study tests a new approach to help your body use insulin better, which may improve blood sugar control and slow down kidney disease. It is for people with advanced chronic kidney disease and type 2 diabetes who are not yet on dialysis.
Phoenix, ArizonaAges 18 years+ - NCT03913819Recruiting
Standard treatment for bladder problems caused by substance abuse
This trial tests how well a set “standard” treatment plan works for people with bladder emptying problems caused by substance abuse. You might consider it if you have this specific type of bladder issue and can follow the treatment plan.
ShatinAges Any age - NCT07011433Enrolling by invitation
Pneumonia germs, inflammation, and recovery
This study looks at how certain parts of the bacteria that cause pneumonia (called virulence factors) and your body's natural inflammation markers are related to how well you recover. The goal is to learn more about what affects pneumonia outcomes, which could help doctors personalize treatment.
KaunasAges 18 years+ - NCT06908473Enrolling by invitationPhase 3
Tongmai Jiangtang capsule for heart risks in metabolic syndrome
This trial tests whether the Tongmai Jiangtang capsule can reduce serious heart and stroke problems in older adults with metabolic syndrome who are also at high risk for heart disease. It focuses on people with a specific traditional Chinese medicine pattern called Qi-deficiency and Blood Stasis.
Guangzhou, GuangdongAges 65 years+ - NCT05933733Recruiting
Salvage treatment for breast cancer that returned locally
This trial looks at how well “salvage” treatments work for breast cancer that has come back only in the local area (like the chest wall or nearby lymph nodes), without spreading to distant organs. It also tracks side effects to better understand the risks and benefits for patients who need additional treatment.
SeoulAges 18–100 - NCT06722755Recruiting
CPAP for Sleep Apnea After Stroke
This study tests whether using a CPAP machine (a device that helps you breathe while sleeping) can improve recovery after a recent stroke or brain bleed. You may join if you had a stroke in the past month and are not already using CPAP.
Downey, CaliforniaAges 18 years+ - NCT06722378Recruiting
Helping families read hospital notes for kids
This trial tests whether letting parents read the doctor's notes about their child during a hospital stay helps them feel more involved and reduces anxiety. It's for parents of children under 12 on general pediatric floors.
Los Angeles, CaliforniaAges 18 years+ - NCT06504485Recruiting
Study of bulevirtide for chronic hepatitis B and D
This trial tests a drug called bulevirtide for people with chronic hepatitis B and D (HDV) co-infection. It looks at how the immune system and virus respond to treatment.
MilanAges 18 years+ - NCT04896255Recruiting
Long-term follow-up of hepatitis B treatments
This study looks at long-term outcomes in people with chronic hepatitis B who take antiviral medicines or receive interferon. It may help doctors understand which treatments work best over time and who is most likely to benefit.
ShanghaiAges 18 years+ - NCT04289142RecruitingPhase 4
Testing memory effects of dexmedetomidine during heart surgery
This study looks at how a sleep medicine called dexmedetomidine affects thinking and memory after heart surgery. It compares cognitive outcomes over time to see if this sedation choice changes long-term brain function.
Vancouver, British ColumbiaAges 60 years+ - NCT05489965Recruiting
Looking at voice outcomes in people using a TEP after laryngectomy
This study follows people who have had their voice box fully removed (total laryngectomy) and who use a TEP (a specific type of voice device). It aims to understand whether voice results differ between men and women.
La Jolla, CaliforniaAges 18 years+ - NCT02872987Recruiting
Adult blood cancer registry study with stored samples
This study enrolls adults with certain blood cancers to better understand diagnosis, treatment choices, and outcomes. You may also be asked to provide or have tissue/blood samples saved so researchers can study what’s going on in the disease.
GrazAges 18 years+ - NCT02622581Recruiting
Lung cancer research registry for treatment and outcomes
This study collects information from people with lung cancer to understand how different treatments work and what outcomes they have. It includes patients with non-small cell lung cancer (NSCLC) or small cell lung cancer (SCLC) at various stages.
OldenburgAges 18 years+ - NCT07635316Recruiting
Treatment patterns and outcomes in neuroendocrine tumors
This study examines how doctors treat gastroenteropancreatic neuroendocrine tumors (rare slow-growing cancers of the stomach, pancreas, or intestines) and how patients respond. Researchers will review medical records from 2018–2025 to understand which treatments work best and help improve care for future patients.
East Hanover, New JerseyAges 18–110 - NCT04537689RecruitingPhase 4
Test ixekizumab and stopping it in plaque psoriasis
This study looks at how well ixekizumab (an injection medication) works for moderate-to-severe plaque psoriasis, and what happens when the treatment is withdrawn. It may help you learn whether stopping the medicine is safe and how skin disease outcomes change over time.
Outram ParkAges 22–90 - NCT05326334Recruiting
Study gut microbiome in new glioblastoma patients
This trial studies how changes in gut bacteria (gut microbiome) relate to outcomes in people with newly diagnosed glioblastoma receiving standard chemo-radiation. It may help doctors learn which gut-bacteria patterns go along with better or worse results during treatment.
Ottawa, OntarioAges 18 years+
Hear when a new Patient Outcomes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for patient outcomes?
- Yes. Clin2 currently lists 648 recruiting patient outcomes studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a patient outcomes trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a patient outcomes trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.